Trial intelligence / Profile preview

Effect-site controlled, reaction-time safeguarded, patient-maintained propofol sedation in healthy volunteers

2005-005443-26Phase 4Unknown

Sponsor
NHS Greater Glasgow and Clyde
Start
Feb 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol in procedural sedation and analgesia (PSA), sponsored by NHS Greater Glasgow and Clyde. Primary endpoints: Maximal change in oxygen saturation, Maximal change in respiratory rate and 1 more. Status: unknown.

02

Drugs

propofol
03

Conditions

procedural sedation and analgesia (PSA)

Beyond the preview

Go deeper on 2005-005443-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005443-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call